logo

For the Inventor, By the Inventor

London, United Kingdom

Tularik Limited


USPTO Granted Patents = 126


Forward Citations = 1,478

Loading Chart...
Loading Chart...

119 inventors (with patents filed for the assignee):

goldMedal David V Goeddel (17 out of 92 patents)

silverMedal Mike Rothe (15 out of 44 patents)

bronzeMedal Bei Shan (14 out of 37 patents)

4.  Jin-Long Chen (14 out of 20 patents)

5.  Zhaodan Cao (13 out of 15 patents)

6.  Julio Cesar Medina (13 out of 73 patents)

7.  John A Flygare (11 out of 55 patents)

8.  Jonathan B Houze (10 out of 56 patents)

9.  Juan Carlos Jaen (9 out of 42 patents)

10.  Bohdan Waszkowycz (8 out of 9 patents)

11.  M Catherine Amaral (8 out of 10 patents)

12.  David Louis Clark (8 out of 14 patents)

13.  Terry J Rosen (7 out of 31 patents)

14.  Ning Zhang (6 out of 6 patents)

15.  Jay Patrick Powers (5 out of 123 patents)


Core Competencies:
Serine Protease Inhibitors
Pentafluorobenzenesulfonamides
Biaryl Compounds
IRAK-4 Compositions
CXCR3 Antagonists
FXR Modulators
PPAR Gamma Activity
NS5B HVC Polymerase Inhibitors
Antibacterial Agents
G-Protein Coupled Receptors
Nuclear Hormone Receptor Assays
Polycyclic Compounds

126 patents:

1. 7928137 - Meta-benzamidine derivatives as serine protease inhibitors (2011-04-19),
2. 7381734 - Serine protease inhibitors (2008-06-03),
3. 7220781 - Meta-benzamidine derivatives as serine protease inhibitors (2007-05-22),
4. 7157585 - Serine protease inhibitors (2007-01-02),
5. 7074934 - Serine protease inhibitors (2006-07-11),
6. 7067516 - Serine protease inhibitors (2006-06-27),
7. 6962929 - Pentafluorobenzenesulfonamides and analogs (2005-11-08),
8. 6916957 - Serine protease inhibitors (2005-07-12),
9. 6869975 - Linked biaryl compounds (2005-03-22),
10. 6822001 - Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents (2004-11-23),
11. 6818419 - IRAK-4: compositions and methods of use (2004-11-16),
12. 6809104 - Fused heterocyclic compounds (2004-10-26),
13. 6794379 - CXCR3 antagonists (2004-09-21),
14. 6780858 - Antibacterial agents (2004-08-24),
15. 6777446 - FXR modulators (2004-08-17),
Tularik Limited is a leading pharmaceutical company specializing in the research, development, and commercialization of innovative drugs for various therapeutic areas. With a mission to improve global health outcomes, Tularik Limited combines cutting-edge technology, scientific expertise, and a patient-centric approach to deliver high-quality and life-changing medications. Our commitment to scientific innovation and ethical practices has earned us recognition as a trusted partner and employer of choice in the pharmaceutical industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

126 Patents

#33 in London

#131 in United Kingdom

#6,178 in the World

...
London, United Kingdom

Tularik Limited

Forward Citations = 1,478

119 inventors:

goldMedal David V Goeddel (17 out of 92 patents)

silverMedal Mike Rothe (15 out of 44 patents)

bronzeMedal Bei Shan (14 out of 37 patents)

4.  Jin-Long Chen (14 out of 20 patents)

5.  Zhaodan Cao (13 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…